PURPOSE: It has been reported that elevated PRL-3 expression was closely associated with lymph node metastasis of gastric cancer. In the present study, we detected the expression of PRL-3 in primary gastric cancer tissue, and evaluated its prognostic impact on the patients. METHODS: Total 137 gastric tumor samples were measured for PRL-3 phosphatase expression using immunohistochemistry method, and the overall survival rate was compared between the patients with high PRL-3 expression (n = 85) and those with moderate or low PRL-3 expression (n = 52) in the primary tumor. RESULTS: PRL-3 expression was more frequently detected in the tumors with a diameter >40 mm and in advanced stages (TNM stage III or IV). Furthermore, the overall survival rate of the patients with high expression of PRL-3 in the primary tumor was significantly less than those with moderate or low expression (P < 0.001). CONCLUSIONS: PRL-3 expression is associated with gastric cancer progression. Its high expression in the primary lesion had a negative impact on the prognosis of the patients. This strongly suggests that PRL-3 should be considered as a prognostic factor.
PURPOSE: It has been reported that elevated PRL-3 expression was closely associated with lymph node metastasis of gastric cancer. In the present study, we detected the expression of PRL-3 in primary gastric cancer tissue, and evaluated its prognostic impact on the patients. METHODS: Total 137 gastric tumor samples were measured for PRL-3 phosphatase expression using immunohistochemistry method, and the overall survival rate was compared between the patients with high PRL-3 expression (n = 85) and those with moderate or low PRL-3 expression (n = 52) in the primary tumor. RESULTS:PRL-3 expression was more frequently detected in the tumors with a diameter >40 mm and in advanced stages (TNM stage III or IV). Furthermore, the overall survival rate of the patients with high expression of PRL-3 in the primary tumor was significantly less than those with moderate or low expression (P < 0.001). CONCLUSIONS:PRL-3 expression is associated with gastric cancer progression. Its high expression in the primary lesion had a negative impact on the prognosis of the patients. This strongly suggests that PRL-3 should be considered as a prognostic factor.
Authors: W F Matter; T Estridge; C Zhang; R Belagaje; L Stancato; J Dixon; B Johnson; L Bloem; T Pickard; M Donaghue; S Acton; R Jeyaseelan; V Kadambi; C J Vlahos Journal: Biochem Biophys Res Commun Date: 2001-05-25 Impact factor: 3.575
Authors: Belinda S Parker; Pedram Argani; Brian P Cook; Han Liangfeng; Scott D Chartrand; Mindy Zhang; Saurabh Saha; Alberto Bardelli; Yide Jiang; Thia B St Martin; Mariana Nacht; Beverly A Teicher; Katherine W Klinger; Saraswati Sukumar; Stephen L Madden Journal: Cancer Res Date: 2004-11-01 Impact factor: 12.701
Authors: U A Miskad; S Semba; H Kato; Y Matsukawa; Y Kodama; E Mizuuchi; N Maeda; K Yanagihara; H Yokozaki Journal: Virchows Arch Date: 2007-01-18 Impact factor: 4.064
Authors: Manas K Pathak; Deepika Dhawan; Daniel J Lindner; Ernest C Borden; Carol Farver; Taolin Yi Journal: Mol Cancer Ther Date: 2002-12 Impact factor: 6.261
Authors: Carmen M Dumaual; George E Sandusky; Han Weng Soo; Sean R Werner; Pamela L Crowell; Stephen K Randall Journal: Am J Transl Res Date: 2012-01-05 Impact factor: 4.060
Authors: Renée Beekman; Marijke Valkhof; Stefan J Erkeland; Erdogan Taskesen; Veronika Rockova; Justine K Peeters; Peter J M Valk; Bob Löwenberg; Ivo P Touw Journal: PLoS One Date: 2011-10-20 Impact factor: 3.240